Hitachi Medical Systems Europe Holding AG
3
Good health runs in families / Hitachi Medical Systems Europe welcomes five new family members to the diagnostic ultrasound series at the European Society of Radiology
plus
Actualités de Tokyo
Advanced GUIDESOLE(TM) technology introduces a unique sensation for runners that reduces energy loss at the ankle joint to boost running efficiency
Tokyo (ots/PRNewswire) - ASICS today turned the world of running on its head as it revealed a completely new concept in run efficiency, METARIDE(TM). One of ASICS' most important innovations in seven decades, and as part of ASICS' ambition to help all runners to WIN THE LONG RUN1, the shoe was designed with one ...
plusAlliance Members Achieve Combined Sales of 10.76 Million Units in 2018
Paris and Tokyo (ots/PRNewswire) - - Combined sales by Renault, Nissan and Mitsubishi Motors rise 1.4% to 10.76 million units in 2018 - one in nine of all cars and light commercial vehicles sold worldwide - Total sales of Light Commercial Vehicles (LCVs) rise 13.5% to 2 million - Cumulative sales of electric vehicles up 34% year-over-year, to 725,000 electric vehicles ...
plusTeijin Invests in Dutch Venture Elitac to Expand Total Safety Solutions
Tokyo (ots/PRNewswire) - The Teijin Group (https://www.teijin.com/) announced today that on November 29 it acquired 25,000 shares, or 20 percent of the outstanding shares of Elitac B.V. (http://www.elitac.nl/), a startup company that develops textiles and clothing integrated with wearable sensing devices, located in Utrecht, The Netherlands. The shares were purchased ...
plusHitachi Medical Systems Europe Holding AG
2Hitachi Medical Systems Europe introduces the third generation of non-invasive intracardiac blood flow visualization technology, at EuroEcho Imaging 2018
plusKyowa Kirin Announces POTELIGEO® Receives Marketing Authorisation in Europe for the Treatment of Mycosis Fungoides and Sézary Syndrome
Tokyo (ots/PRNewswire) - POTELIGEO will be the first biologic agent targeting CCR4 to be available for patients in Europe. Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) announces today that it has received a European Commission decision granting a marketing authorisation to POTELIGEO® (Generic name: mogamulizumab), a ...
plus
KLM Holdings Reports on Samsung, With Higher Profits and a New Product Line
Tokyo (ots/PRNewswire) - KLM Holdings (https://www.klmholdings.com/) research and analysis department has commented on Samsung as they will announce their new foldable smartphone to its developer conference this week. The new device will be a new concept both in its design and user interface. Samsung has already recorded a higher operating profit at around $15.5 ...
plusAlliance Ventures Invests in Transit to Advance Multi-Modal Transportation and Mobility-as-a-Service Strategy
Paris, Tokyo, and Yokohama, Japan (ots/PRNewswire) - Transit's mobile app aggregates and maps real-time transportation data, functional in more than 175 metropolitan areas around the world Alliance Ventures, the strategic venture capital arm of Renault-Nissan-Mitsubishi, has announced today that it has invested in ...
plusAlliance Ventures Leads Strategic Investment in WeRide.ai
Paris, Tokyo and Yokohama, Japan (ots/PRNewswire) - Renault-Nissan-Mitsubishi and WeRide.ai to increase presence in Chinese autonomous vehicle services Alliance Ventures, the strategic venture capital arm of Renault-Nissan-Mitsubishi, has become the lead strategic investor of WeRide.ai (formerly JingChi.ai), China's leading autonomous driving company focused on Level 4 (L4) self-driving technology, following completion of ...
plusAlliance Ventures Invests in Data Ecosystem for Shared Transport Services
Paris, Tokyo, and Yokohama, Japan (ots/PRNewswire) - Alliance Ventures, the corporate venture capital fund of Renault-Nissan-Mitsubishi, the world's largest automotive group by unit sales, today announced that it led a $5 million Series A investment in Coord (https://coord.co), the US mobility data platform. (Logo: ...
plusKyowa Kirin Presents Data at EORTC-Cutaneous Lymphoma Task Force Meeting Showing Significantly Improved Quality of Life for Patients With Mycosis Fungoides (MF) and Sézary Syndrome (SS) on Mogamulizumab
Tokyo (ots/PRNewswire) - First oral presentation of Quality of Life data from the phase III trial (MAVORIC), the largest randomised trial in MF and SS - the two most common types of Cutaneous T Cell Lymphoma[1] Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) announces that Quality of Life (QoL) data from the pivotal ...
plusFEI Fédération Equestre Internationale
World's biggest equine airlift for FEI World Equestrian Games(TM) Tryon 2018
plus
Kyowa Kirin Announces FDA Approval of Poteligeo® (mogamulizumab-kpkc) for the Treatment of Mycosis Fungoides and Sézary Syndrome
Tokyo (ots/PRNewswire) - - Poteligeo has been approved for the treatment of the two most common types of Cutaneous T-cell lymphoma (CTCL) in previously treated patients based on data showing improved progression-free survival (PFS) and overall response rate (ORR) when compared to vorinostat. - FDA approval was based ...
plusEntrepreneurCountry Global Limited
The 8th Annual Follow The Entrepreneur Summit Touches Down in Dubrovnik, Croatia
Zagreb, Croatia (ots/PRNewswire) - Leading 300 Entrepreneurs & Business Leaders Expected in This Adriatic Idyllic Vielle Ville 7-10 October 2018 Dubbed the SALT of European Venture Capital last year in Malta, the annual pilgrimage by leading entrepreneurs and business leaders to listen to breakthrough ideas, and entrepreneurs sharing their visions has come to Dubrovnik ...
plusRenault-Nissan-Mitsubishi Achieves Record First-Half Sales of 5.54 Million Units
Paris, Tokyo and Yokohama, Japan (ots/PRNewswire) - Sales Rise 5.1 Percent Amid Solid Demand For Models Sold By Alliance Member Companies Renault-Nissan-Mitsubishi, the world's largest automotive alliance, today announced that unit sales at its member companies rose 5.1 percent to a new record of 5,538,530 vehicles in the six months to June 30. (Logo: ...
plusAstellas Pharma Europe Limited
Results From Pivotal Phase 3 PROSPER Trial of XTANDI[TM] (enzalutamide) in Men With Non-Metastatic Castration-Resistant Prostate Cancer Published in New England Journal of Medicine
Tokyo (ots/PRNewswire) - Results show enzalutamide plus androgen deprivation therapy significantly reduced the risk of developing metastases or death by 71 percent compared to placebo plus androgen deprivation therapy[i] FOR EMEA MEDICAL MEDIA ONLY - Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji ...
plusRenault - Nissan - Mitsubishi Increase Annual Synergies to EUR5.7 Billion
Paris, Tokyo and Yokohama, Japan (ots/PRNewswire) - - Annual synergies rise 14%, from EUR5 billion in 2016 to EUR5.7 billion in 2017 - Mitsubishi Motors reports first full year of synergies as Alliance member - Further convergence underway in Aftersales, Quality & Total Customer Satisfaction and Business Development - The Alliance reaffirms synergy target of more than ...
plusUltragenyx and Kyowa Kirin Announce Topline Phase 3 Study Results Demonstrating Superiority of Crysvita® (burosumab) Treatment to Oral Phosphate and Active Vitamin D in Children with X-Linked Hypophosphatemia (XLH)
Novato, California, Tokyo and London (ots/PRNewswire) - Substantial Healing of Rickets Observed in 72% of Patients Treated with Crysvita Compared to 6% of Patients Receiving Conventional Therapy at 40 Weeks Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel ...
plus
Alliance Accelerates Convergence in Key Functions to Support and Deliver Mid-term Plan
Paris, Yokohama, Japan and Tokyo (ots/PRNewswire) - Project Leaders Appointed to Drive Increased Cooperation and New Synergy Opportunities as Part of Alliance 2022 Highlights of the new project initiative include: - Extended convergence in Purchasing, Engineering and Manufacturing & Supply Chain - Two new converged functions in Quality & Total Customer Satisfaction as ...
plusJonathan Adashek Appointed Alliance Global Vice President, Communications, at Renault-Nissan-Mitsubishi
Paris, Yokohama, Japan and Tokyo (ots/PRNewswire) - Alliance Strengthens Communications Leadership Renault-Nissan-Mitsubishi, the world's largest automotive alliance, today announced that Jonathan Adashek has been appointed Alliance Global Vice President, Communications, with immediate effect. (Logo: ...
plusRenault-Nissan-Mitsubishi and DiDi Chuxing Sign MOU to Explore Car-sharing Partnership in China
Paris, Tokyo, and Yokohama, Japan (ots/PRNewswire) - Renault-Nissan-Mitsubishi, the world's leading automotive alliance, today announced it has signed a memorandum of understanding with DiDi Chuxing ('DiDi'), the leading Chinese mobile transportation platform, to explore future business cooperation on a new electric vehicle car-sharing program in the People's Republic ...
plusRenault-Nissan-Mitsubishi Sells 10.6 Million Vehicles in 2017
Paris, Yokohama and Tokyo, Japan (ots/PRNewswire) - - Combined sales by Renault, Nissan and Mitsubishi Motors rise 6.5% to 10,608,366 units in 2017 - one in nine passenger cars and light commercial vehicles sold worldwide - Zero-emission leadership maintained with cumulative sales of 540,623 electric vehicles since 2010 Renault-Nissan-Mitsubishi, the world's leading automotive Alliance, today announced that its member ...
plusJapan's Economy Hits A Winning Streak Reports Shinhan Daiwa Brokerage
Tokyo (ots/PRNewswire) - Shinhan Daiwa Brokerage said that the Japanese economy is rapidly expanding at a rate that has not been seen in more than a decade. Shinhan Daiwa Brokerage (https://sdbholdings.com/) has commented on recent data reports that confirm the economic growth the Japanese economy is currently experiencing. The research and analysis department at ...
plusRenault-Nissan-Mitsubishi Sponsors Women's Forum Global Meeting
Paris, Yokohama and Tokyo, Japan (ots/PRNewswire) - - Renault-Nissan-Mitsubishi is the main sponsor of the Women's Forum 2017 Global Meeting, the world's leading conference for women on major social and economic issues, reflecting the Alliance's commitment to diversity - The Alliance, global leader in electric vehicles with over 500,000 EV units sold worldwide, will provide a fleet of electric vehicles to transport ...
plus
Alliance 2022: New Plan Targets Annual Synergies of EUR10 Billion and Forecasts Unit Sales of 14 Million & Combined Revenues of $240 Billion
Paris and Tokyo (ots/PRNewswire) - RENAULT, NISSAN & MITSUBISHI MOTORS TO STRENGTHEN COOPERATION AND ACCELERATE USE OF COMMON PLATFORMS, POWERTRAINS & NEW TECHNOLOGIES New six-year plan set to achieve the following objectives: - More than 9 million vehicles to share four common platforms - Proportion of common ...
plusGlaxoSmithKline Japan Selects SciBite Semantic Platform to Enhance Pharmacovigilance Capabilities
Tokyo and Cambridge, England (ots/PRNewswire) - SciBite - The award-winning semantic analytics company, today announced that GlaxoSmithKline K.K. (hereinafter referred to as GSK Japan), one of Japan's leading research-based pharmaceutical and healthcare companies, has selected SciBite's Semantic Platform to enhance ...
plusThe Japanese Ministry of Health, Labor and Welfare Approved Exablate Neuro System for the Treatment of Essential Tremor
Tokyo and Haifa, Israel (ots/PRNewswire) - INSIGHTEC (http://www.insightec.com/JP/), the leader in MR-guided Focused Ultrasound (MRgFUS) therapy, announced today that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved its Exablate Neuro system for the non-invasive treatment of essential tremor in ...
plusAstellas Announces Transfer of Qutenza(TM) to Grünenthal
Tokyo and Chertsey, England (ots/PRNewswire) - Astellas Pharma Inc. (President and CEO: Yoshihiko Hatanaka, "Astellas"), today announced that Astellas Pharma Europe Ltd., ("Astellas Pharma Europe") has entered into a definitive agreement with Grünenthal under which Astellas Pharma Europe will transfer the exclusive rights for Qutenza(TM) (capsaicin 8% patch) in Europe, Middle East and Africa to Grünenthal. (Logo: ...
plusAstellas to Acquire Ganymed Pharmaceuticals
Tokyo and Mainz, Germany (ots/PRNewswire) - - Acquisition Would Expand Astellas' Oncology Pipeline with Antibody in Late-Stage - Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") and Ganymed Pharmaceuticals AG (CEO; Özlem Türeci, "Ganymed"), a biopharmaceutical company located in Mainz, Germany which focuses on the development of antibodies against cancer, announced today that Astellas ...
plusWorld Anti-Doping Agency and Astellas Announce Global Initiative to Prevent Misuse and Abuse of Medicines for Doping in Sports
Montreal and Tokyo (ots/PRNewswire) - The World Anti-Doping Agency (President: Sir Craig Reedie, "WADA") and Astellas Pharma Inc. (TSE: 4503: President and CEO: Yoshihiko Hatanaka, "Astellas") today announced a global agreement to partner on the prevention of misuse and abuse of medicines for doping in sports. ...
plus
Précédent1234Suivant